Brief: Ampio Pharmaceuticals Provides Corporate Update

Ampio Pharmaceuticals

27/03/2019 24:24

March 26 (Reuters) - Ampio Pharmaceuticals Inc  AMPE.A :
    * AMPIO PHARMACEUTICALS PROVIDES CORPORATE UPDATE
    * AMPIO PHARMACEUTICALS - ON MARCH 11, RESUBMITTED SPECIAL
PROTOCOL ASSESSMENT WITH FDA FOR CONFIRMATORY PHASE III CLINICAL
TRIAL OF AMPION
    * FDA CONFIRMED THEY WOULD RESPOND TO SPA SUBMISSION NO
LATER THAN
APRIL 25, 2019
    * COMPANY BELIEVES ANTICIPATED COST OF TRIAL IS MANAGEABLE
AND
WITHIN RANGE OF OTHER OAK TRIALS
    * WE PLAN TO CONTINUE SEEKING A PARTNERSHIP FOR OPTINA

Source text for Eikon:  ID:nPn8682SPa 
Further company coverage:  AMPE.A 

 ((Reuters.Briefs@thomsonreuters.com;))